| Not Yet Recruiting | A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Mon NCT07482657 | Enanta Pharmaceuticals, Inc | Phase 2 |
| Withdrawn | Safety and Immunogenicity Study of SCB-1019T in Children NCT06666179 | Clover Biopharmaceuticals AUS Pty | Phase 1 |
| Recruiting | Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France NCT06881953 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protectio NCT06866405 | Pfizer | Phase 3 |
| Recruiting | Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults NCT06843317 | Clover Biopharmaceuticals USA, LLC | Phase 1 |
| Completed | A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy NCT06917508 | Enanta Pharmaceuticals, Inc | Phase 1 |
| Terminated | Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection NCT06784973 | Gilead Sciences | Phase 2 |
| Completed | A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazol NCT06847464 | Enanta Pharmaceuticals, Inc | Phase 1 |
| Recruiting | Real-World Effectiveness of Perinatal RSV Immunoprophylaxis NCT06172660 | Yale University | — |
| Terminated | Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection NCT06585150 | Gilead Sciences | Phase 2 |
| Recruiting | CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools NCT06640387 | The Hospital for Sick Children | — |
| Completed | Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Resp NCT06583031 | Sanofi Pasteur, a Sanofi Company | Phase 1 |
| Recruiting | RSV Vaccination in Immunocompromised Patients. NCT06597916 | Medical University of Vienna | Phase 2 |
| Active Not Recruiting | A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults NCT06442241 | Guangzhou Patronus Biotech Co., Ltd. | Phase 1 |
| Completed | A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults NCT06601192 | Enanta Pharmaceuticals, Inc | Phase 1 |
| Enrolling By Invitation | Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection NCT06401720 | Karolinska Institutet | — |
| Recruiting | Prevalence and Impact of Pertussis and RSV on Asthma Severity and Control NCT06286007 | Hospital Clinico Universitario de Santiago | — |
| Enrolling By Invitation | Epidemiological and Clinical Characteristics of Hospitalized Patients Under 5 Years Old With RSV Infection in NCT05767294 | Tongji Hospital | — |
| Unknown | Evaluation of Lung Ultrasonography Findings in Newborns With Respiratory Syncytial Virus Bronchiolitis NCT06204367 | Kırıkkale University | — |
| Unknown | An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Trans NCT06490549 | Institute of Hematology & Blood Diseases Hospital, China | — |
| Completed | A Controlled Phase 2a Study to Evaluate the Efficacy of EDP-323 Against Respiratory Syncytial Virus Infection NCT06170242 | Enanta Pharmaceuticals, Inc | Phase 2 |
| Unknown | FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol NCT05928507 | Baebies, Inc. | — |
| Recruiting | Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization NCT06180993 | Federico Martinón Torres | — |
| Unknown | Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Pro NCT06259487 | Wroclaw Medical University | N/A |
| Active Not Recruiting | SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies NCT05765396 | The Geneva Foundation | — |
| Completed | A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV NCT05779995 | Hangzhou Sciwind Biosciences Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit NCT06008457 | Sequenom, Inc. | — |
| Unknown | Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens. NCT05765838 | Rigshospitalet, Denmark | N/A |
| Withdrawn | Analysis of Lung Sounds Collected by RESP Biosensor to Support Decision Making in Monitored Hospitalized Pedia NCT05661422 | Strados Labs, Inc. | — |
| Completed | Project STARFISH - PRJ0002679 NCT05727202 | Thermo Fisher Scientific, Inc | — |
| Completed | Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study NCT05794412 | University Hospital, Geneva | — |
| Completed | A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications. NCT05568706 | Enanta Pharmaceuticals, Inc | Phase 2 |
| Unknown | Respiratory Syncytial Virus (RSV) Burden in Older Adults in Primary Care in The Netherlands NCT06318936 | UMC Utrecht | — |
| Active Not Recruiting | Diagnosis and Treatment Status and Medical Burden of Respiratory Syncytial Virus Infection in Children in Chin NCT07264478 | Beijing Children's Hospital | — |
| Unknown | Infant RSV Infections and Health-related Quality of Life of Families NCT05550545 | Global Foundation for the Care of Newborn Infants | — |
| Completed | A Study of EDP-323 in Healthy Subjects NCT05587478 | Enanta Pharmaceuticals, Inc | Phase 1 |
| Unknown | Towards Life-Long Healthy Lungs: A Multidisciplinary Follow-up Framework for Preterm Infants NCT05618769 | Franciscus Gasthuis | N/A |
| Unknown | Impact of the Covid-19 on RSV NCT05348616 | Hospices Civils de Lyon | — |
| Completed | Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial V NCT04520659 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessme NCT05268939 | LumiraDx UK Limited | N/A |
| Completed | Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) D NCT04938830 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults NCT05118386 | Gates Medical Research Institute | Phase 1 |
| Completed | Severity of RSV Infections in Twins NCT05070975 | Hospices Civils de Lyon | — |
| Completed | Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic NCT04944160 | Hospices Civils de Lyon | — |
| Completed | Drug-Drug Interaction Study Between Fluconazole and EDP-938 in Healthy Subjects NCT04871724 | Enanta Pharmaceuticals, Inc | Phase 1 |
| Completed | Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults NCT04752644 | Bavarian Nordic | Phase 2 |
| Recruiting | RSV Burden in Outpatient and Hospital Settings NCT04743609 | Association Clinique Thérapeutique Infantile du val de Marne | N/A |
| Completed | Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine NCT04690335 | Meissa Vaccines, Inc. | Phase 2 |
| Suspended | Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus PO NCT04782336 | LumiraDx UK Limited | N/A |
| Completed | Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children NCT04484935 | AstraZeneca | Phase 2 |
| Completed | Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Sub NCT04498741 | Enanta Pharmaceuticals, Inc | Phase 1 |
| Withdrawn | Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV NCT04267822 | Pfizer | Phase 2 |
| Unknown | Respiratory Syncytial Virus Infection May be More Dangerous in Neonate NCT04531735 | Dr. Behcet Uz Children's Hospital | — |
| Terminated | Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Manageme NCT05105191 | Erasme University Hospital | N/A |
| Unknown | Predictors of Respiratory Syncytial Virus (RSV) Hospitalizations in Infants NCT04144816 | Hospices Civils de Lyon | — |
| Terminated | Emission Patterns of Respiratory Syncytial Virus NCT03909867 | Wake Forest University Health Sciences | — |
| Completed | RSV Study in Adults 60 to 75 Years of Age NCT03919591 | Hvivo | N/A |
| Completed | Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects NCT03755778 | Enanta Pharmaceuticals, Inc | Phase 1 |
| Completed | The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial Virus NCT03728413 | Imperial College London | N/A |
| Completed | Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects NCT03750383 | Enanta Pharmaceuticals, Inc | Phase 1 |
| Completed | A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model NCT03691623 | Enanta Pharmaceuticals, Inc | Phase 2 |
| Completed | Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 a NCT03596801 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Study of EDP-938 in Healthy Subjects NCT03384823 | Enanta Pharmaceuticals, Inc | Phase 1 |
| Completed | Evaluating the Infectivity, Safety, and Immunogenicity of a Respiratory Syncytial Virus Vaccine (RSV 6120/∆NS2 NCT03387137 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Active Not Recruiting | RESCEU: Defining the Burden of RSV Disease NCT03698084 | University of Oxford | — |
| Unknown | RESCEU Study, Defining the Burden of Disease of RSV in Older Adults NCT03621930 | UMC Utrecht | — |
| Unknown | RESCEU Study: Defining the Burden of Disease of Respiratory Syncytial Virus in Europe in Infants NCT03627572 | UMC Utrecht | — |
| Completed | Nasal and Bronchial Absorption Sampling in RSV Bronchiolitis NCT03062917 | Imperial College Healthcare NHS Trust | N/A |
| Completed | Effect of Heliox on RSV Bronchiolitis NCT03171142 | Wael Seliem | Phase 3 |
| Completed | ALX-0171 Phase I Pharmacokinetic Study in Healthy Male Volunteers NCT01875926 | Ablynx, a Sanofi company | Phase 1 |
| Completed | A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806 NCT01801293 | Gilead Sciences | Phase 1 |
| Completed | ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers NCT01483911 | Ablynx, a Sanofi company | Phase 1 |
| Terminated | Intranasal Challenge of Healthy Adults With Respiratory Syncytial Virus (RSV) NCT01475305 | MedImmune LLC | Phase 1 |
| Completed | Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study NCT01090557 | Winthrop University Hospital | — |